We focus on proven molecules, new formulations, and indications to lower scientific risks and fulfill unmet needs in important and financially attractive markets.

To support our vision to become a fully integrated specialty pharma company, we plan to establish a specialized commercial team to support marketing of our products in the United States in epilepsy and other specialty areas.